TY - JOUR
T1 - Echocardiographic changes in patients with malignant phase hypertension
T2 - The West Birmingham malignant hypertension register
AU - Nadar, S.
AU - Beevers, D. G.
AU - Lip, G. Y.H.
N1 - Funding Information:
We acknowledge the support of the Sandwell and West Birmingham Hospitals NHS Trust Research and Development programme. We thank Nicola Beaumont for assistance with data collection.
PY - 2005/1
Y1 - 2005/1
N2 - In order to study the echocardiographic abnormalities in consecutive patients with malignant phase hypertension (MHT), we reviewed echocardiograms of 31 patients (23 male; mean age 52±14 years) with MHT who were admitted to our unit. Trans-thoracic echocardiography was carried out in all patients, and echocardiographic measurements were compared with those of 39 patients (30 male; mean age 54±10 years with controlled nonmalignant essential hypertension, and 32 (19 male; mean age 51 ± 10 years) healthy normotensive volunteers. Patients with MHT had a significantly higher mean systolic and diastolic blood pressure (P<0.001) compared to the other two groups. MHT patients had significantly greater mean left atrial dimensions (P=0.002), as well as aortic root dimensions (P=0.01) and left ventricular (LV) dimensions (with the exception of the diastolic internal diameter) (P<0.001). MHT patients also had a mean larger LV mass and LV mass index (both P<0.001) when compared to the other two groups. The mean ejection fraction was also lower in the MHT group (P<0.001). In conclusion, patients with MHT have significant cardiac hypertrophy, in association with systolic dysfunction and dilated left atria, irrespective of the duration of known hypertension. These abnormalities may predispose MHT patients to cardiovascular complications including heart failure and cardiac arrhythmias, such as atrial fibrillation.
AB - In order to study the echocardiographic abnormalities in consecutive patients with malignant phase hypertension (MHT), we reviewed echocardiograms of 31 patients (23 male; mean age 52±14 years) with MHT who were admitted to our unit. Trans-thoracic echocardiography was carried out in all patients, and echocardiographic measurements were compared with those of 39 patients (30 male; mean age 54±10 years with controlled nonmalignant essential hypertension, and 32 (19 male; mean age 51 ± 10 years) healthy normotensive volunteers. Patients with MHT had a significantly higher mean systolic and diastolic blood pressure (P<0.001) compared to the other two groups. MHT patients had significantly greater mean left atrial dimensions (P=0.002), as well as aortic root dimensions (P=0.01) and left ventricular (LV) dimensions (with the exception of the diastolic internal diameter) (P<0.001). MHT patients also had a mean larger LV mass and LV mass index (both P<0.001) when compared to the other two groups. The mean ejection fraction was also lower in the MHT group (P<0.001). In conclusion, patients with MHT have significant cardiac hypertrophy, in association with systolic dysfunction and dilated left atria, irrespective of the duration of known hypertension. These abnormalities may predispose MHT patients to cardiovascular complications including heart failure and cardiac arrhythmias, such as atrial fibrillation.
KW - Echocardiography
KW - Malignant hypertension
UR - http://www.scopus.com/inward/record.url?scp=12744280979&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=12744280979&partnerID=8YFLogxK
U2 - 10.1038/sj.jhh.1001773
DO - 10.1038/sj.jhh.1001773
M3 - Article
C2 - 15457204
AN - SCOPUS:12744280979
SN - 0950-9240
VL - 19
SP - 69
EP - 75
JO - Journal of Human Hypertension
JF - Journal of Human Hypertension
IS - 1
ER -